UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics

mAbs, 2021-01, Vol.13 (1), p.1982447-1982447

2021

Volltextzugriff (PDF)

Virotherapy Research in Germany: From Engineering to Translation

Human gene therapy, 2017-10, Vol.28 (10), p.800-819

2017

Volltextzugriff (PDF)

Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds

PloS one, 2014-04, Vol.9 (4), p.e95723-e95723

2014

Volltextzugriff (PDF)

Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation

Journal of Immunology Research, 2016-01, Vol.2016 (2016), p.1-17

2016

Volltextzugriff (PDF)

Gene Therapy "Made in Germany": A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy

Human gene therapy, 2021-10, Vol.32 (19-20), p.987-996

2021

Volltextzugriff (PDF)

Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells

Molecular therapy, 2006-08, Vol.14 (2), p.164-174

2006

Volltextzugriff (PDF)

Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma

Human gene therapy, 2007-01, Vol.18 (1), p.51-62

2007

Volltextzugriff (PDF)

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach

Cancer Immunology, Immunotherapy, 2018-04, Vol.67 (4), p.513-523

2018

Volltextzugriff (PDF)

Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism

Cancer biology & therapy, 2003-09, Vol.2 (5), p.511-515

2003

Volltextzugriff (PDF)

Gene therapy: designer promoters for tumour targeting

Trends in Genetics, 2000-04, Vol.16 (4), p.174-181

2000

Volltextzugriff (PDF)

Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy

Human gene therapy, 2004-05, Vol.15 (5), p.509-518

2004

Volltextzugriff (PDF)

Insulated hsp70B′ promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses

The journal of gene medicine, 2008-04, Vol.10 (4), p.340-354

2008

Volltextzugriff (PDF)

Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy

Human gene therapy, 2011-04, Vol.22 (4), p.389-404

2011

Volltextzugriff (PDF)

Targeting of Adenovirus to Endothelial Cells by a Bispecific Single-Chain Diabody Directed against the Adenovirus Fiber Knob Domain and Human Endoglin (CD105)

Molecular therapy, 2001-06, Vol.3 (6), p.882-891

2001

Volltextzugriff (PDF)

Transcriptional targeting of tumors with a novel tumor-specific survivin promoter

Cancer gene therapy, 2004-04, Vol.11 (4), p.256-262

2004

Volltextzugriff (PDF)

Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv

The journal of gene medicine, 2004-06, Vol.6 (6), p.642-651

2004

Volltextzugriff (PDF)

Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo

Virology (New York, N.Y.), 2004-03, Vol.320 (1), p.121-134

2004

Volltextzugriff (PDF)

An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy

International journal of oncology, 2007-11, Vol.31 (5), p.1177-1185

2007

Volltextzugriff (PDF)

Evaluation of tissue-specific promoters in carcinomas of the cervix uteri

The journal of gene medicine, 2004-11, Vol.6 (11), p.1281-1289

2004

Volltextzugriff (PDF)

Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways

Cancer gene therapy, 2005-02, Vol.12 (2), p.162-174

2005

Volltextzugriff (PDF)

TUMOR-BUSTING VIRUSES

Scientific American, 2003-10, Vol.289 (4), p.68-75

2003

Volltextzugriff (PDF)

Promoter Optimization and Artificial Promoters for Transcriptional Targeting in Gene Therapy

Vector Targeting for Therapeutic Gene Delivery, 2002, p.481-503

2002

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaGene Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Adenoviridae - Genetics
(12)
Animals
(12)
Genetics & Heredity
(12)
Medicine, Research & Experimental
(12)
Research & Experimental Medicine
(12)
Biotechnology & Applied Microbiology
(11)
Adenovirus
(9)
Genetic Vectors
(9)
Tumors
(9)
Cancer
(8)
Cell Line, Tumor
(8)
Genetic Therapy
(8)
Mice
(7)
Female
(6)
Gene Transfer Techniques
(6)
Melanoma
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies

Virotherapy Research in Germany: From Engineering to Translation

Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds

Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation

Gene Therapy "Made in Germany": A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy

Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells

Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach

Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism

Gene therapy: designer promoters for tumour targeting

Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy

Insulated hsp70B′ promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses

Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy

Targeting of Adenovirus to Endothelial Cells by a Bispecific Single-Chain Diabody Directed against the Adenovirus Fiber Knob Domain and Human Endoglin (CD105)

Transcriptional targeting of tumors with a novel tumor-specific survivin promoter

Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv

Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo

An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy

Evaluation of tissue-specific promoters in carcinomas of the cervix uteri

Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways

TUMOR-BUSTING VIRUSES

Promoter Optimization and Artificial Promoters for Transcriptional Targeting in Gene Therapy

Aktive Filter

Suchergebnisse filtern